2025-26 Tax Developments Impacting Tax-Exempt Healthcare
Daniel Hennessey, Shareholder in Stevens & Lee’s Health Care Group, will lead the session “2025-26 Tax Developments Impacting Tax-Exempt Healthcare” on Mar. 12 at 10:45 a.m. Discussion will cover a range of tax issues and developments over 2025 and early 2026 that specifically impact charitable providers and other members of the tax-exempt healthcare industry. Topics covered would include IRS exempt organization initiatives, regulatory changes and rulings, trends in Section 501(c)(3) compliance and enforcement, tax exemption and community benefit standards for hospitals, tax-exempt M&A and corporate structure topics and developments in state/local tax exemption matters, including on-going Pennsylvania real estate tax exemption disputes, among other salient issues.
The Department of Justice’s Treatment of Healthcare
Jerry Karam and Ryan O’Neill, Co-Chairs of Stevens & Lee’s White Collar Defense and Investigations Group, alongside Tamara J. Haken, an Assistant U.S. Attorney for the Middle District of Pennsylvania, will present “Primer and Update on DOJ’s Treatment of Healthcare Companies” on Mar. 12 at 2:00 p.m. As announced in DOJ’s May 2025 “White Collar Enforcement Plan,” criminally prosecuting Healthcare Fraud clearly remains a priority of the Trump administration. On the civil side, vigorous enforcement of False Claims Act cases against healthcare companies continues. This session will provide a primer on DOJ’s revised corporate enforcement program and its impact on the health care companies and individuals within a health care company. The session also will discuss DOJ’s expanded whistleblower program and added incentives for corporate self-disclosure.
Hosted by:
Convene Conference Center
Philadelphia, PA
